About this trial
Vulval cancer is a rare cancer, affecting about 70 women in Ireland each year. Survivors may face challenges related to treatment side effects, sexual functioning, body image, and relationships. The Mater Hospital is conducting a survey in which they aim to understand the long term impact vulvar cancer has on patients and how it’s treatments can impact a woman’s life. This is including physical health, emotional well-being and sexual functioning.
Patient Profile
History of vulval cancer, not undergoing active CT/RT.
Where’s this trial being run?
Mater Misericordiae University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | Vulval Cancer: A Focus on Survivorship |
|---|---|
| Number: | 25-40 |
| Full Title: | Vulval Cancer in Ireland: A Focus on Survivorship. A cross-sectional study to evaluate quality-of-life indices in survivors of vulval cancer. |
| Principal Investigator: | Prof. Donal Brennan (with Dr. Aisling McDonnell) |
|---|---|
| Type: | |
| Sponsor: | |
| Recruitment Started: |
Global: Ireland: April 2025 |
| Global Recruitment Target: | |
|---|---|
| Ireland Recruitment Target: | 100-110 |